Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Mbio|May 28, 2020
Decreased, Deformed, Defective-How HIV-1 Vpu Targets PeroxisomesKristina Hopfensperger, Daniel SauterCell Reports|March 25, 2021
Sarbecovirus ORF6 proteins hamper induction of interferon signalingIzumi Kimura, Yoriyuki Konno, Keiya Uriu, et al.Journal of Virology|June 5, 2023
Inhibition of Infectious HIV-1 Production by Rerouting the Cellular Furin Inhibitor Serpin B8Moritz Petersen, Rishikesh Lotke, Kristina Hopfensperger, et al.Plos One|November 12, 2015
A Naturally Occurring rev1-vpu Fusion Gene Does Not Confer a Fitness Advantage to HIV-1Simon M Langer, Kristina Hopfensperger, Shilpa S Iyer, et al.Plos Pathogens|November 15, 2021
Evolutionary plasticity of SH3 domain binding by Nef proteins of the HIV-1/SIVcpz lentiviral lineageZhe Zhao, Riku Fagerlund, Helena Tossavainen, et al.Cell Host & Microbe|January 12, 2018
Human-Specific Adaptations in Vpu Conferring Anti-tetherin Activity Are Critical for Efficient Early HIV-1 Replication In VivoEri Yamada, Shinji Nakaoka, Lukas Klein, et al.Mbio|July 16, 2020
Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2Kristina Hopfensperger, Jonathan Richard, Christina M Stürzel, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 18, 2025
Class switch toward IgG2 and IgG4 is more pronounced in BNT162b2 compared to mRNA-1273 COVID-19 vaccineesAlex S Siebner, Johanna Griesbaum, Kelsey E Huus, et al.Elife|February 6, 2019
HIV-1 Vpu is a potent transcriptional suppressor of NF-κB-elicited antiviral immune responsesSimon Langer, Christian Hammer, Kristina Hopfensperger, et al.Pageof 1